Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ianthus Capital Holdings Inc C.IAN

Alternate Symbol(s):  ITHUF

iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures.


CSE:IAN - Post by User

Post by KerBeron Dec 05, 2018 10:06pm
274 Views
Post# 29073323

Beacon Securities Target for IAN.

Beacon Securities Target for IAN.
Beacon also likes iAnthus Capital Holdings (iAnthus Capital Stock Quote, Chart CSE:IAN), to which it ascribes a Buy rating and a recently increased C$16.00 target, representing a 161 per cent projected return. IAN also produced a strong Q3, say the analysts, who are looking forward to news on the opening of the companys first dispensaries in Florida and New York sometime this month, along with the closing of the MPX Bioceutical acquisition next month.
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse